DOCSLIB.ORG

Asi News June 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Asi News June 2019 ASI NEWS JUNE 2019 DAY OF IMMUNOLOGY APRIL 29TH P20 CONTACT US AUSTRALIAN AND NEW 10 41 ZEALAND SOCIETY FOR IMMUNOLOGY INC. A GENTLE ADVOCATE, ICB: DAY OF IMMUNOLOGY ASI INC. SECRETARIAT AN INSPIRATION AND SPECIALS PO BOX 1371, EDUCATOR NEW WAYS TO SHOWCASE MITCHAM NORTH 3132 MARGARET BAIRD WOMEN IN RESEARCH AND TO MAKE IT PH: 03 8393 9388 IMMUNOLOGY AWARD MORE ACCESSIBLE immunology.org.au/contact-us 48th Annual Scientific Meeting of The Australian and New Zealand Society for Immunology Adelaide Convention Centre, South Australia 8 - 12 December 2019 www.asi2019.org SAVE The Organising Committee cordially invite THE DATE you to participate in the 48th Annual Scientific 8-12 December 2019 Meeting of The Australasian Society for ADELAIDE, SA Immunology taking place from 8-12 December 2019 in Adelaide, South Australia. The Conference aims to provide another innovative and dynamic scientific program. We are putting together a varied and balanced program spread over 5 days to showcase the best immunological research from Australia and around the world. With a wide-range of topics from tumour immunology, inflammation, autoimmunity, infectious disease, translational immunology and more, we will ensure there is something for everyone. Preparations are well underway and we anticipate an intellectually Key Dates challenging time, as well as an enjoyable opportunity to experience South Australia and its unique environment. The Organising Committee Registration Open are preparing an engaging social program to give you a flavour of South 3 May 2019 Australian culture and cuisine. Call for Abstracts Open Adelaide is a modern, dynamic, vibrant and lifestyle city with direct access 3 May 2019 to Australia’s best wine regions and stunning scenery, making it an ideal destination for pre and post-Conference touring. It is home to world-class Call for Abstracts Close restaurants, a diverse nightlife, stylish shops and more. 30 August 2019 We look forward to welcoming you to Adelaide! Abstract Notifications 27 September 2019 Adelaide Convention Centre The Adelaide Convention Centre is conveniently located in the heart of Early-bird / Presenter Registration Close the city centre and nestled within the beauty of the Riverbank Precinct, 4 October 2019 surrounded by parklands and the River Torrens. Special Interest Group Workshops Close proximity to the medical hub, entertainment, cultural and sport 8 December 2019 precinct, the Centre is a short walk to international and boutique hotels and accommodation. Public transport, the Adelaide Railway Station and a ASI2018 Conference taxi ramp are on our doorstep. 8 – 12 December 2019 48th Annual Scientific Meeting of ASI NEWSLETTER JUNE 2019 The Australian and New Zealand Society for Immunology Adelaide Convention Centre, South Australia CONTENTS 8 - 12 December 2019 EDITORIAL ............................................................ 4 DOI IN VICTORIA .................................................21 www.asi2019.org SAVE Curiosity Begins from a Conversation Gabriela Khoury Angelica Lau DOI IN NSW ........................................................ 25 The Organising Committee cordially invite THE DATE LETTER FROM THE PRESIDENT ......................... 6 Public Forum on Asthma, Centenary Institute ..25 you to participate in the 48th Annual Scientific 8-12 December 2019 John Fraser Helen McGuire Meeting of The Australasian Society for ADELAIDE, SA NOTE FROM THE HONARARY SECRETARY ..... 7 DoI Museum of Human Disease at UNSW .......26 Immunology taking place from 8-12 Elissa Deenick Fabio Luciani December 2019 in Adelaide, South Australia. Day of Immunology: Garvan Discovery WOMEN’S INITIATIVE ON THE MOVE ............... 9 The Conference aims to provide Tour for school students .....................................27 Kylie Quinn another innovative and dynamic scientific program. Angelica Lau We are putting together a varied and balanced program A GENTLE ADVOCATE, AN INSPIRATION The Day of Immunology: Fake Wounds spread over 5 days to showcase the best immunological research from AND EDUCATOR .................................................10 and Vaccination Campaigns ............................. 30 Margaret Baird Women in Immunology Award Australia and around the world. With a wide-range of topics from tumour Sinead Henderson, Richard Charlesworth Kylie Quinn immunology, inflammation, autoimmunity, infectious disease, translational and Natkunam Ketheesan immunology and more, we will ensure there is something for everyone. STAY TUNED: VSP PROGRAM ............................12 DOI SNAPS FROM SOUTH AUSTRALIA ........... 32 Stuart Mannering Preparations are well underway and we anticipate an intellectually DOI SNAPS FROM NEW ZEALAND .................. 33 Key Dates challenging time, as well as an enjoyable opportunity to experience BRANCH REPORTS ............................................. 14 DOI 2019 IN THE MEDIA ...................................... 34 South Australia and its unique environment. The Organising Committee WA Branch Report .............................................. 14 Registration Open Gabriela Khoury are preparing an engaging social program to give you a flavour of South Bree Foley, WA Councillor 3 May 2019 Australian culture and cuisine. QLD Branch Report ............................................. 16 TRAVEL REPORT ................................................ 38 Keystone Symposium on B Cell-T Cell Call for Abstracts Open Adelaide is a modern, dynamic, vibrant and lifestyle city with direct access Sumaira Hasnain, QLD Councillor Interactions, Keystone, Colorado, USA 3 May 2019 to Australia’s best wine regions and stunning scenery, making it an ideal VIC/TAS Branch Report ...................................... 17 Oanh Nguyen destination for pre and post-Conference touring. It is home to world-class Scott Mueller, VIC/TAS Councillor Call for Abstracts Close ICB: DAY OF IMMUNOLOGY SPECIALS ............. 41 restaurants, a diverse nightlife, stylish shops and more. NSW Branch Report ............................................ 18 30 August 2019 New ways of showcasing our content We look forward to welcoming you to Adelaide! Helen McGuire, NSW branch Councillor Anne La Flamme Abstract Notifications NEWS FROM FIMSA ............................................19 27 September 2019 Adelaide Convention Centre PUBLICATIONS OF INTEREST ........................... 46 Joanna Groom Our Sustaining Members The Adelaide Convention Centre is conveniently located in the heart of Early-bird / Presenter Registration Close DAY OF IMMUNOLOGY 2019 .............................20 the city centre and nestled within the beauty of the Riverbank Precinct, AUSTRALIAN AND NEW ZEALAND 4 October 2019 Gabriela Khoury surrounded by parklands and the River Torrens. SOCIETY FOR IMMUNOLOGY INC. ................... 49 Special Interest Group Workshops Close proximity to the medical hub, entertainment, cultural and sport 8 December 2019 precinct, the Centre is a short walk to international and boutique hotels and accommodation. Public transport, the Adelaide Railway Station and a ASI2018 Conference taxi ramp are on our doorstep. 8 – 12 December 2019 9 20 38 WOMEN’S INITIATIVE DAY OF IMMUNOLOGY KEYSTONE SYMPOSIUM ON THE MOVE This year events were ON B CELL-T CELL A conversation is hosted at 23 participating INTERACTIONS institutes around Australia happening and I Dr Oanh Nguyen, and New Zealand. encourage you to be a University of Melbourne, part of it. 03 EDITORIAL ASI NEWSLETTER JUNE 2019 EDITORIAL: CURIOSITY BEGINS FROM A CONVERSATION Angelica Lau, Newsletter Editor [email protected] With the successful launch of Day of Immunology celebrations across Australia and New Zealand on 29th April, what better time is there than now to engage and recruit new generation of scientists? The point of an outreach program is no doubt to raise awareness for immunology and medical research, but more importantly it serves the purpose of educating the public about facts and myths in research, interventions and developments. These are golden opportunities for us to clarify any misconceptions surrounding some of these important aspects of medicine. In this edition, it is my delight to present to you the amazing effort many volunteers and fellow researchers have put in to make this educational initiative a reality. This is most fitting as ASI have just launched the Margaret Baird Women in Immunology Award (read more about this in the Women’s Initiative Program section), to honor and celebrate the legacy of Margaret Baird who was a phenomenal teacher and female scientist in the Immunology community. 4 EDITORIAL ASI NEWSLETTER JUNE 2019 A new campaign to connect At the Studio: Artwork Submissions you with the next generation scientists out there through art and conversation, to bring about excitement and instill inspiration wherever they are. Carrying on with the same enthusiasm, we have a new campaign to connect you with the next generation scientists out there through art and conversation, to bring about excitement and instill inspiration wherever they are. In order to encourage regular conversations about science between students, parents, teachers, scientists, we are now accepting artwork submissions from school students throughout years 1-12 featuring these following themes: ARTWORK BY DAMIAN TANGYE, AGE 11, “THE B CELLS”. “DAD TELLS ME HE WORKS ON B CELLS; AFTER DOING SOME READING THIS IS HOW I PICTURED A “B CELL” WOULD LOOK!” • What makes up our immune system? • Tricking the immune system to fight cancer • How
Load more

Recommended publications
  • Gender Equity Post-COVID-19
    ISeptembermmunology 2020 | ISSN 1356-5559 (print) News Gender equity post-COVID-19: coordinating our efforts to preserve diversity UK Coronavirus The UK Our first fully Immunology Immunological Open Access Consortium: Toolbox: journal Immunotherapy bringing immunology a hub for veterinary www.immunology.org together immunological reagents Advances 2 ADVERTISEMENTS 1 CytoFLEX, Kaluza and Duraclone are for research use only. Not for diagnostic purposes. All other products identifi ed are not for use in diagnostic procedures. The CytoFLEX, MET ONE 3400, PAT700, Multisizer 4e, Vi-CELL XR, Vi-CELL MetaFLEX, and Kaluza are designed to support GMP compliance. The Multisizer 4e, Vi-CELL XR, and Vi-CELL MetaFLEX are for Laboratory Use Only. © 2018 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. T-Cell_Anzeige_190x129mm_2.indd 1 26.03.20 11:59 Known for quality and reliability, InvivoGen provides cutting-edge tools Take your research to the research community worldwide to the next level InvivoGen’s innovative products: TLRs & innate immunity PRR ligands Reporter cell lines Inhibitors Antibodies & vaccination Mycoplasma detection & elimination Selective antibiotics COVID-19 Cloning and expression vectors Genes and promoters Custom services More information: www.invivogen.com Immunology News | September 2020 A WORD FROM THE EDITOR 3 ©©Shutterstock/howcolour Welcome to the autumn issue of Immunology This new issue also features an overview of News. Here, we look back at what we’ve been the impact of COVID-19 on gender inequity. doing to continue supporting our members Members from the Australian and New and feeding into public discussion around Zealand Society for Immunology provide COVID-19, including our three webinar a perspective from Societies, EMCRs and series and our new infographics on PCR educators, and how we can plan for the future.
    [Show full text]
  • The Bursa of Fabricius Award 12 ASI Councillors' News 13 Caption Competition 16 ASI Inc
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 March 2004 How to win a Nobel Prize in Physiology or Medicine Gordon Ada, John Curtin School of Medical Research When one thinks of winners of Nobel Prizes November to celebrate his contributions and at the Institute for 19 years when Frank came in these disciplines, there is a tendency to achievements. Peter and Rolf were present as to visit me in 1967. He told me he had visualize mature scientists who after many well as many of his past students (from 1972 relinquished the Headship of the Department years of laboratory work have accumulated to 2003) and others who worked in the of Microbiology to become the Director of lots of evidence to prove a particular concept Department, mainly in the 1970s. The the John Curtin School. He asked whether I or theory. This certainly happens, but there contributions, especially by past students, would let my name go forward as a candidate are many other situations. For example, one were remarkable for the variety of topics to succeed him as Head of the Microbiology recipient has provided the concept which a presented. Department? I decided yes, because under co-recipient has independently proven it to Frank Fenner, the Microbiology Department be correct. (e.g. Immunological tolerance, In the late 1960s I was happily working at the had reached international status and if I went Burnet and Medawar, 1960). In contrast, the Walter and Eliza Hall Institute (WEHI) with there, I could bring virology and immunology 1996 Prize resulted from a rather unusual Gus Nossal as a close colleague.
    [Show full text]
  • 2006 Annual Report
    Centenary Institute report annual 06 OUR LOGO The letter “C” set in sandstone in the logo, has dual symbolism. It reflects our commitment to cancer research and, as the Roman Numeral for 100, it represents our association with the Centenaries of the University of Sydney Medical School and Royal Prince Alfred Hospital. Our mission To improve the quality of life for all Australians through excellence in medical research Centenary Institute Annual Report 2006 www.centenary.org.au 3 Contents Page 2006 Highlights 4 Director’s Report 6 From The Chairman 7 Report from Incoming Executive Director 8 Board of Governors 9 Our History 11 Organisational Chart 12-13 Research Groups 14 Cell Biology 14 Gene and Stem Cell Therapy 18 Liver Immunobiology 20 Molecular Cardiology 25 Mycobacterial Research 26 T Cell Biology 29 Core Facilities 31 Postgraduate Training Programme 33 2006 Seminar Series 35 2006 Publications 38 2006 Presentations 41 Centenary Committees 47 2006 Staff List 48 2007 – The Year Ahead 51 Fundraising 53 Centenary Institute Annual Report 2006 4 2006 Highlights • Centenary Institute’s Agnes Ginges Centre for Molecular capacity of infected macrophages to die through Cardiology, headed by Associate Professor Chris apoptosis and kill mycobacteria. In separate studies Semsarian, have identified several ‘killer’ genes the group showed that the recently recognised believed to be responsible for sudden cardiac death cytokine IL-23 is effective for increasing the immune (SCD) following tests on more than 400 Australian response and protective effect of DNA vaccines against families with a history of heart disease. The group is TB and that this cytokine can compensate for IL-12 amongst the first to report the association between deficiency in controlling TB in mice.
    [Show full text]
  • Influenza Susceptibility Linked to Variable Responses to Interferons in the Lung
    MEDIA RELEASE Wed 11th December 2019 Influenza susceptibility linked to variable responses to interferons in the lung Researchers at the Centenary Institute and the University of Sydney have discovered a key reason as to why the influenza virus is so effective at establishing infection and causing damage in the lungs. They found that a group of lung-cells, following influenza infection, responded only poorly to interferons (the signalling proteins that help defend the body against viral attack). The research could pave the way for the development of new and improved anti-influenza drugs and vaccines, to both improve health and to save lives. “Interferons are critically essential to our defence against pathogens including the influenza virus,” said Associate Professor Carl Feng, senior study author from the Centenary Institute and the University of Sydney. “The proteins are so named because they ‘interfere’ with the ability of viruses to multiply in the body.” “It’s been known for a long time that during influenza, lung cells and immune cells in the lungs secrete interferons causing virus-infected cells to initiate anti-viral defences,” said Associate Professor Feng. “However, how interferons actually undertake this protective activity is still not understood because the signalling proteins can act on hundreds of different types of cells in our body,” he said. In their study, Associate Professor Feng and colleagues have generated a new tool to identify which cells respond to interferons in influenza infected mice. The goal was to work out whether the outcome of infection and interferon signalling differed between different cell types. What the researchers have demonstrated in the study is that not every cell type reacts equally to the interferons, even when they are in close proximity to each other.
    [Show full text]
  • Editorial: the Role of Innate Lymphoid Cells in Mucosal Immunity
    EDITORIAL published: 17 June 2020 doi: 10.3389/fimmu.2020.01233 Editorial: The Role of Innate Lymphoid Cells in Mucosal Immunity Jessica G. Borger 1*†, Graham Le Gros 2† and Joanna R. Kirman 3† 1 Department of Immunology and Pathology, Central Clinical School, Monash University, Alfred Research Alliance, Melbourne, VIC, Australia, 2 Allergic & Parasitic Diseases Programme, Malaghan Institute of Medical Research, Wellington, New Zealand, 3 Department of Microbiology & Immunology, University of Otago, Dunedin, New Zealand Keywords: ILC, NK cell, mucosal, immunity, lung, gastrointestinal tract, genitourinary tract Editorial on the Research Topic The Role of Innate Lymphoid Cells in Mucosal Immunity Innate Lymphoid Cells (ILCs) are tissue-resident innate cells that are deeply integrated within mucosal tissues and play a critical role in tissue homeostasis and inflammatory processes. The collection of articles in this Frontiers Research Topic investigates and discusses the new and emerging roles of ILCs in mucosal immunity. The field of ILC biology has increased exponentially in recent years. Although the scientific Edited and reviewed by: community had been aware of the existence of certain innate cells of lymphoid origin for many Marina Cella, Washington University School of years, it has only been in the past decade that the full extent of the ILC family and their Medicine in St. Louis, United States wide-reaching biological roles has been recognized. As the field expanded, to avoid confusion due to the different names being used in the literature for the same ILC subsets, in 2013 it was *Correspondence: Jessica G. Borger proposed that ILCs should be divided into three broad lineages based on specific transcription [email protected] factor expression and the cytokines they produce.
    [Show full text]
  • Survey of Commercial Outcomes from Public Research (Scopr) 2019 Report
    techtransfer.org.au SURVEY OF COMMERCIAL OUTCOMES FROM PUBLIC RESEARCH (SCOPR) 2019 REPORT Survey and report delivered by FOREWORD There is an ever-present imperative to capture the commercial value of our research endeavour for our future wellbeing. To do so strategically, decision makers from laboratory, institutional and government levels need insights into how the research sector is currently engaging with industry to transfer knowledge and innovation, and thereby deliver benefits to our society from the fruits of our research. For many years in Australia there has been a focus on improving innovation metrics, thus I am delighted to acknowledge the initiative of gemaker and Knowledge Commercialisation Australasia (KCA) in producing the inaugural Survey of Commercial Outcomes from Public Research (SCOPR). The SCOPR takes its lead from the National Survey of Research Commercialisation (NSRC) produced since 2000 by the Department of Industry, Science, Energy and Resources. To avoid duplication, the Department has decided to cease the NSRC and will work with KCA to share knowledge, and access data collected by SCOPR. As we face the COVID-19 pandemic, effective knowledge transfer is more important than ever, so I hope that this report will spur our research institutions to even greater achievements. Realising effective knowledge transfer will depend on having skilled commercialisation professionals who can help researchers turn great ideas into beneficial products and services. I applaud KCA’s support for technology transfer professionals
    [Show full text]
  • EMJ-Respiratory-8.1-2020-1.Pdf
    RESPIRATORY European Edition Vol. 8.1 November 2020 emjreviews.com + ERS INTERNATIONAL CONGRESS 2020 + EDITOR’S PICK + INTERVIEWS Two ERS 2020 Award Winners Improving Antenatal provide fascinating insights into their area of expertise in Asthma Management: cardiopulmonary rehabilitation A Complex Journey and intensive care medicine. + ABSTRACT REVIEWS Captivating reviews of abstracts presented at ERS International Congress 2020. WELCOME TO THE BREATHING HOTSPOT. Visit www.wehale.life/hcp GO TO DESTINATION FOR HEALTHCARE PROFESSIONALS WORKING WITH ASTHMA AND COPD • Patient support materials • Instruction and tutorial videos • Information about the Easyhaler® product family ENTER CHECK THE LATEST SCIENTIFIC INSIGHTS Terapia wziewna – ze szczególnym uwzględnieniem steroidów – w okresie pandemii COVID-19. Scientific Presentations at Virtual ERS Congress 2020 Performance under simulated www.wehale.life/de/Corona/ Sponsored by Orion Pharma. real-life conditions. Cercano al inhalador ideal: fácil y conveniente. (NL) Switching asthma and COPD patients to Easyhaler® Potilaiden tyytyväisyys inhalaattoriin Costs of switching to low global warming leads to improved clinical outcomes and QOL. on yhteydessä parempaan hoitomyönty- potential inhalers. UK Prescribing Information (FR) Pharmacokinetics of salmeterol and fluticasone vyyteen ja astman hoitotasapainoon. propionate delivered in combination via Easyhaler® Evaluation of the efficiency of single-inhaler and Diskus® dry powder inhalers. combination therapy with budesonide/ Adverse events should
    [Show full text]
  • Discovery First Step to New Therapies Many of Our Scientists Have Achieved Strong Results in Their Research Throughout the Year
    Newsletter of the Centenary Institute OCTOBER 08 LuminesCent Dr Mika Jormakka hopes to improve treatments for diseases like cancer by mapping complex Welcome to the October 2008 issue of structures called membrane proteins. LuminesCent, wrapping up a very busy and exciting year for the Centenary Institute. Discovery first step to new therapies Many of our scientists have achieved strong results in their research throughout the year. In this edition we In an Australian first, scientists at the Centenary Institute have mapped the feature two, Dr Mika Jormakka (page 1) and Associate anatomy of a membrane protein. This exciting discovery has the potential to turn Professor Chris Semsarian (page 5), who had their work the way we discover new drugs on its head and reduce the development time published in highly respected international journals. for new treatments. One of our promising young researchers, Dr Jeff Holst, of “These membrane proteins are the target for 70% of all therapeutic drugs so the Gene and Stem Cell Therapy program, talks about an increased understanding of them is vital for future drug discoveries,” said his investigations into prostate cancer, the most common Centenary Institute Executive Director, Professor Mathew Vadas. cancer diagnosed in Australian men, on page 4. The Centenary Institute recently unveiled a confocal Publishing in the prestigious international journal, Nature Structural & Molecular microscope that produces 3D images and video for Biology, Dr Mika Jormakka, head of Centenary’s Structural Biology laboratory, says improved investigation of diseases such as cancer and understanding membrane protein structures will help develop better treatments heart disease. Read about it on page 2.
    [Show full text]
  • 2005 Annual Report
    Centenary Institute report annual 05 OUR LOGO The letter “C” set in sandstone in the logo, has dual symbolism. It reflects our commitment to cancer research and, as the Roman Numeral for 100, it represents our association with the Centenaries of the University of Sydney Medical School and Royal Prince Alfred Hospital. Our mission To improve the quality of life for all Australians through excellence in medical research Centenary Institute Annual Report 2005 www.centenary.org.au 3 Contents Page 2005 Highlights 4 Director's Report 7 Farewell to Professor Antony Basten 8 Interim Director's Report 10 Board Governors 11 Our History 13 Organisational Chart 14 Research Groups 16 Cell Biology 16 Antibody Gene Recombination & Mutation 16 Cancer Drug Resistance 17 Lymphocyte Differentiation 18 Molecular & Cellular Responses 19 Type 1 Diabetes 20 Cellular Immunity 21 Gene and Stem Cell Therapy 22 Liver Immunobiology 24 Liver Immunology 24 Molecular Hepatology 25 Transplantation 26 Molecular Cardiology 28 Mycobacterial Research 29 Host Responses to Infection 30 Vaccine Development & Mycobacterial Pathogenesis 31 T Cell Biology 32 Core Facilities 34 Postgraduate Training Programme 36 2005 Seminar Series 38 2005 Publications 40 2005 Presentations 43 Centenary Committees 51 2005 Staff List 52 Research Groups 52 2006 - The Year Ahead…. 55 Fundraising 56 Centenary Institute Annual Report 2005 4 2005 Highlights Major equipment upgrade • Associate Professor Chris Semsarian, head of Centenary's Agnes Ginges Centre for Molecular In June 2005 Centenary took delivery of three new flow Cardiology, was the runner-up in the 2005 Royal Prince cytometers from BD Biosciences valued at $1.7 million, Alfred Research Medal presentations.
    [Show full text]
  • Biomarker Signature Found for TB Infection
    MEDIA RELEASE 8 May 2020 Biomarker signature found for TB infection A group of leading Australian researchers have uncovered a unique blood-based biomarker signature in individuals infected by tuberculosis (TB). The presence of the biomarker signature, found through a simple blood test, allows individuals with infectious TB–including those with non-symptomatic early-stage disease– to be easily identified and treated. The finding, reported in the Journal of Infection, could be key in supporting health efforts to control and eventually eliminate the TB epidemic which is responsible for approximately 1.5 million deaths each year globally. “A major issue in controlling the spread of tuberculosis is the difficulty of detecting the disease quickly and effectively, particularly in developing countries and in remote areas where technology and testing facilities may be limited,” says lead author of the study, Dr Jennifer Ho from the Centenary Institute and the Woolcock Institute of Medical Research “Sputum smear microscopy is the test used to diagnose TB in the majority of endemic settings but it is unable to pick-up TB in its early stages which prevents timely diagnosis and treatment.” “Also problematical are individuals with latent TB who possess no physical sickness or symptoms,” she says. “Unaware they are infected, these individuals can become TB spreaders if their disease progresses at some point to an active state.” Dr Ho notes that it is estimated that over 3.3 million cases of active TB are undetected annually, contributing to the uncontrolled spread of TB. “Our biomarker discovery could be used as the basis for a highly effective and simple diagnostic blood test to help detect these prevalent cases of TB in the community,” she says.
    [Show full text]
  • Snow Fellowships 2020 Application Round - Eligible Host Organisations
    Snow Fellowships 2020 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Mater Research Limited Melanoma Institute Australia Menzies School of Health Research Monash University Murdoch Children’s Research Institute Murdoch
    [Show full text]
  • 2012 Annual Report (3.9MB PDF File)
    Annual Report RESEARCH2012 HIGHLIGHT OF THE YEAR Our group has made significant advances in understanding disease progression related to iron metabolism, but also on a more translational level, advances in characterising the effects of drug therapies in cancer. We have provided new insight into disease causing iron acquisition through a particular iron transporter, and have characterised specific lead drug candidates targeting the LAT transporters in prostate cancer cells. OUR HISTORY The Centenary Institute opened in 1989, under the stewardship of its founding Director Professor Anthony Basten, to commemorate the centenaries of the University of Sydney Medical School and the Royal Prince Alfred Hospital. Formal working relationships with the University and Hospital have provided unique opportunities for students to become involved both in research and the translation of basic discoveries into clinical practice, an area in which the Institute has become a leader. The Centenary Institute is a world class medical research facility focusing on cancer, cardiovascular and infectious diseases. It is located between Royal Prince Alfred Hospital and the University of Sydney, and forms a critical point of contact and intellectual engagement between the Hospital and the University. 2012 Scientific Image Prize Winner – ‘The Spark of Life’. Dr David Hancock, T cell Biology. Understanding the complexity of the immune system using advanced bioinformatics. A network map displaying all interactions in an immune cell after activation. Centenary Institute
    [Show full text]